menu
    • menu

    Company profile for Bayer AG

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    For over a century, Bayer has stood for improving everyday health and wellness for millions of consumers worldwide. People everywhere make Bayer a trusted part of their daily lives. This deep connection with consumers has fueled the growth and innovation of our product portfolio and we believe that our brands will continue to play a critical role in the health and welfare of people worldwide. Our rich history began in 1897 wit...
    For over a century, Bayer has stood for improving everyday health and wellness for millions of consumers worldwide. People everywhere make Bayer a trusted part of their daily lives. This deep connection with consumers has fueled the growth and innovation of our product portfolio and we believe that our brands will continue to play a critical role in the health and welfare of people worldwide. Our rich history began in 1897 with the synthesis of a stable form of acetylsalicylic acid (ASA), which was introduced to the market as Aspirin™ in 1899. In 1969, Aspirin made it to the moon aboard the Apollo 11 and by the mid-1980’s.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bayer AGGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Mullerstr. 178, 13353 Berlin
    Telephone
    Telephone
    +49 30 468 1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharma.bayer.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    This week, SpeakPharma interviews Miquel Bachs, CEO of Inke, a company with over two decades of expertise in micronization and particle engineering, and a leader in providing high-quality, effective solutions in the global fight against chronic respiratory diseases such as COPD and asthma. In this insightful conversation, Bachs shares Inke’s strategic vision, technological innovations, and commitment to sustainability, offering a comprehensive look at how the company is shaping the future of respiratory health. HIGHLIGHTS// Inke’s strategic vision/ technological innovations/ commitment to sustainability Studies suggest that 13 percent of people over 40 years of age, the world over, have chronic obstructive pulmonary disease (COPD). Given the increasing prevalence of respiratory diseases, how does Inke position itself as a leader in the development and manufacturing of respiratory APIs? Inke has established itself as a global leader in generic respiratory API development through our unique blend  of technological innovation, expertise in micronization, and a comprehensive portfolio of inhalation therapies. With over 20 years of experience in micronization and particle engineering, our ability to customize APIs to meet specific client requirements has resulted in highly effective, high-quality products tailored for respiratory therapies. The increasing prevalence of chronic respiratory diseases, such as COPD and asthma, has only underscored Inke’s pivotal role in supporting the pharmaceutical industry’s need for advanced treatments. We specialize in bronchodilators and other critical respiratory APIs that improve patient outcomes and meet the stringent regulatory requirements of global health authorities. Our end-to-end approach, from early-stage API development to commercial-scale production, ensures that we maintain the highest standards of quality, safety, and efficacy. As the market for respiratory APIs continues to evolve, Inke remains committed to expanding its portfolio to address unmet therapeutic needs. Beyond respiratory APIs, we are also prioritizing growth in CNS treatments and building on our expertise in complex molecule synthesis. This strategic focus allows us to provide an integrated solution that not only meets current market demands but also anticipates future pharmaceutical trends. HIGHLIGHTS// comprehensive portfolio of inhalation therapies/ over 20 years of experience in micronization and particle engineering/ specialize in bronchodilators and other critical respiratory APIs/ prioritizing growth in CNS treatments In the field of micronization, what differentiates Inke’s approach from that of other manufacturers of respiratory APIs? What sets Inke apart in micronization is our advanced particle size reduction technology and our dedication to precision. Our facility is equipped with various milling techniques such as Cone, Jet, and Pin mills, allowing us to reduce particle size while stabilizing the amorphous content to ensure consistent quality. Our in-depth understanding of respiratory APIs, combined with our ability to tailor solutions for each customer, results in APIs with improved solubility, stability, and bioavailability, which are critical for the efficacy of inhalation products. This, along with our exceptional quality standards and a flawless audit track record, has positioned us as a key partner for major players in the inhalation market. HIGHLIGHTS// advanced particle size reduction technology/ technological innovations/ tailor solutions/ improved solubility, stability, and bioavailability Developing complex APIs can be challenging. How does Inke ensure a smooth and successful partnership throughout the development and manufacturing process, including customization, ensuring regulatory compliance and timely delivery? At Inke, we are dedicated to fostering strong partnerships with our clients through a collaborative approach that prioritizes open communication and mutual understanding. Our commitment to quality and personalized service sets us apart in the pharmaceutical landscape. Our team takes the time to engage in comprehensive discussions to customize our solutions, ensuring alignment with client specifications across all batches and grades. This commitment to flexibility allows us to respond effectively to evolving requirements, solidifying Inke’s reputation as a reliable partner. We understand that navigating regulatory landscapes can be challenging. That's why our team is equipped to manage all aspects of the regulatory process with meticulous attention to detail. From the submission of Drug Master Files (DMFs) and Certificates of Suitability to crafting precise responses to potential Deficiency Letters, we ensure compliance at every step. Moreover, we offer extensive support in patent and intellectual property matters, providing technical assistance and guidance tailored to the specific requirements of each region. Our unwavering dedication to quality, coupled with our agile response capabilities, enables us to deliver exceptional results while maintaining transparency and trust. At Inke, we are committed to building lasting relationships that drive success for both our clients and our organization. HIGHLIGHTS// ensuring alignment with client specifications/ manage all aspects of the regulatory process/ support in patent and intellectual property matters Given Inke’s global presence, what are the key markets for growth and how does Inke plan to expand its market reach and strengthen its position in these regions? Inke is strategically focused on expanding its footprint in the European and US markets, where we continue to prioritize our efforts. The US market remains pivotal for us, especially considering our successful FDA inspections and ongoing regulatory compliance efforts that solidify our reputation. Japan is another significant market where we have established a robust presence, reflecting our commitment to high-quality manufacturing and innovation. Looking ahead, China represents a key growth opportunity for Inke. With 12 active DMFs registered, we are well-positioned to tap into this burgeoning market. Our strategy involves leveraging our existing capabilities to navigate regulatory landscapes and fostering strong partnerships within the region, thereby enhancing our market reach and influence in the pharmaceutical sector. HIGHLIGHTS// expanding footprint in the European and US markets/ China represents a key growth opportunity for Inke With Inke expanding into contract manufacturing organization (CMO) services, how does this new offering align with Inke’s broader strategic goals, and what advantages does it provide to pharmaceutical partners? At Inke, the introduction of CMO services is a natural extension of our core expertise in the development and manufacturing of high-quality generic APIs. Our expansion into CMO is part of a strategic move to diversify our service portfolio, allowing us to offer end-to-end solutions for our clients. The CMO service integrates seamlessly with our expertise in API manufacturing, particularly in micronization, which has been a key differentiator for Inke for over two decades. With our advanced particle engineering capabilities, we can offer tailored solutions that meet specific technical and regulatory requirements. Whether it is small-batch production or scaling up to commercial quantities, we offer the flexibility to accommodate a wide range of customer needs. This adaptability, paired with our deep expertise in micronization, allows us to support evolving project needs, maintaining the highest standards of consistency, quality, and performance that define Inke’s footprint. HIGHLIGHTS// CMO is part of a strategic move to diversify our service portfolio/ deep expertise in micronization What is Inke’s commitment to sustainability and corporate social responsibility and how is it integrating sustainable practices into its operations and product development? At Inke, we recognize that integrating environmental, social, and governance (ESG) principles into our operations is not just a responsibility but a pathway to long-term success. Our ESG vision is centered around aligning business growth with sustainable practices that positively impact our communities and the environment. We are dedicated to environmental responsibility, actively implementing initiatives such as efficient wastewater treatment and water reuse systems to minimize our ecological footprint. Our recent investments in energy efficiency include the installation of a 135 kWp solar panel system, which underscores our commitment to reducing emissions and resource consumption across our manufacturing and research facilities. Inke is also committed to fostering a diverse and inclusive workforce. With a notable increase in our team members, particularly in operations and quality assurance, we prioritize career development and the well-being of our employees. By adhering to high regulatory standards, we ensure our products meet stringent global requirements, enhancing our transparency and compliance. Through these initiatives, Inke aims to cultivate sustainable practices that not only support our business objectives but also contribute positively to the pharmaceutical industry and society at large. HIGHLIGHTS// integrating ESG principles/ efficient wastewater treatment and water reuse systems/ installation of a 135 kWp solar panel system/ diverse and inclusive workforce

    Impressions: 441

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases

    #SpeakPharma With Inke
    28 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2508

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

    #PharmaFlow by PHARMACOMPASS
    24 Oct 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Bayer and Dewpoint sign Licensing Agreement for Heart Disease Program
    Bayer and Dewpoint sign Licensing Agreement for Heart Disease Program

    25 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/24/2968633/0/en/Bayer-and-Dewpoint-Therapeutics-sign-Licensing-Agreement-for-Heart-Disease-Program.html

    GLOBENEWSWIRE
    25 Oct 2024
    Share Share
    Eylea 8 mg Efficacy In Diabetic Macular Edema Confirmed At 3 Years
    Eylea 8 mg Efficacy In Diabetic Macular Edema Confirmed At 3 Years

    19 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/long-term-efficacy-and-safety-profile-of-eylea-8-mg-with-extended-dosing-intervals-in-diabetic-macular-edema-confirmed-at-three-years-16338

    INDPHARMAPOST
    19 Oct 2024
    Share Share
    Bayer submits EU marketing application for menopause relief drug
    Bayer submits EU marketing application for menopause relief drug

    15 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-submits-eu-marketing-application-menopause-relief-drug-2024-10-15/

    REUTERS
    15 Oct 2024
    Share Share
    Bayer applies for third indication of Nubeqa in EU
    Bayer applies for third indication of Nubeqa in EU

    14 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-applies-third-indication-nubeqa-eu-2024-10-14/

    REUTERS
    14 Oct 2024
    Share Share
    Orion's Partner Bayer Submits Application For Darolutamide
    Orion's Partner Bayer Submits Application For Darolutamide

    14 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/14/2962356/0/en/Orion-s-collaboration-partner-Bayer-submits-application-for-third-indication-of-darolutamide-in-the-EU.html

    GLOBENEWSWIRE
    14 Oct 2024
    Share Share
    Bayer must pay $78 million in latest Roundup cancer trial, jury finds
    Bayer must pay $78 million in latest Roundup cancer trial, jury finds

    11 Oct 2024

    // REUTERS

    https://www.reuters.com/legal/bayer-must-pay-78-mln-latest-roundup-cancer-trial-jury-finds-2024-10-10/

    REUTERS
    11 Oct 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Ethinyl Estradiol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Ethinyl Estradiol

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-11

    Pay. Date : 2013-07-05

    DMF Number : 1985

    Submission : 1972-08-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-079 - Rev 07

    Issue Date : 2017-03-03

    Type : Chemical

    Substance Number : 140

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10829

    Registrant's Address : Kaiser-Wilhelm-Allee 1,51373 Leverkusen, Germany

    Initial Date of Registration : 2006-10-20

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12866-1016

    Start Marketing Date : 2017-05-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Iopromide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Iopromide

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 8178

    Submission : 1989-08-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2020-273 - Rev 00

    Issue Date : 2021-01-06

    Type : Chemical

    Substance Number : 1753

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10003

    Registrant's Address : Kaiser-Wilhelm-Allee 1,51373 Leverkusen, Germany

    Initial Date of Registration : 2009-01-13

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Bayer Korea Ltd.

    Registration Date : 2018-07-06

    Registration Number : 20180706-210-J-240

    Manufacturer Name : Bayer AG

    Manufacturer Address : Ernst-Schering-Straße 14 59192 Bergkamen Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Levonorgestrel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Levonorgestrel

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-28

    Pay. Date : 2013-01-08

    DMF Number : 4178

    Submission : 1981-05-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2000-101 - Rev 03

    Issue Date : 2017-03-03

    Type : Chemical

    Substance Number : 926

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10828

    Registrant's Address : Kaiser-Wilhelm-Allee 1,51373 Leverkusen, Germany

    Initial Date of Registration : 2006-10-20

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12866-1010

    Start Marketing Date : 2017-05-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Norethisterone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Norethisterone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 2046

    Submission : 1973-02-08

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-050 - Rev 00

    Issue Date : 2018-07-23

    Type : Chemical

    Substance Number : 234

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10281

    Registrant's Address : Kaiser-Wilhelm-Allee 1,51373 Leverkusen, Germany

    Initial Date of Registration : 2007-09-10

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12866-1013

    Start Marketing Date : 2017-05-13

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    CAS 50-28-2

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    CAS 50-28-2

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3379

    Submission : 1978-11-02

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 222MF10134

    Registrant's Address : Kaiser-Wilhelm-Allee 1,51373 Leverkusen, Germany

    Initial Date of Registration : 2010-04-13

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Drospirenone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Drospirenone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 12138

    Submission : 1996-09-09

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-070 - Rev 02

    Issue Date : 2022-07-27

    Type : Chemical

    Substance Number : 2404

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Bayer Korea Ltd.

    Registration Date : 2006-03-02

    Registration Number : 309-2-ND

    Manufacturer Name : Bayer AG@[Undifferentiated Process Manufacturer] Bayer AG

    Manufacturer Address : Ernst-Schering-Straße 14 59192 Bergkamen, Germany@Max-Dohrn-Straße 8 10589 Berlin, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Gadobutrol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Gadobutrol

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13061

    Submission : 1998-07-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-275 - Rev 02

    Issue Date : 2023-12-06

    Type : Chemical

    Substance Number : 2735

    Status : Valid

     JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Bayer Korea Ltd.

    Registration Date : 2004-11-05

    Registration Number : 309-1-ND

    Manufacturer Name : Bayer AG@Dynamit Nobel GmbH Explosivstoff- und Systemtechnik

    Manufacturer Address : Ernst-Schering-Straße 14 59192 Bergkamen, Germany@Kalkstraße 218 51377 Leverkusen Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Norethisterone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Norethisterone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-05

    Pay. Date : 2013-01-28

    DMF Number : 2726

    Submission : 1976-08-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2023-427 - Rev 00

    Issue Date : 2024-06-12

    Type : Chemical

    Substance Number : 234

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12866-1013

    Start Marketing Date : 2017-05-13

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Norethisterone Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Norethisterone Acetate

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-10-04

    Pay. Date : 2013-09-30

    DMF Number : 2033

    Submission : 1972-12-22

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2000-111 - Rev 04

    Issue Date : 2017-06-22

    Type : Chemical

    Substance Number : 850

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12866-1014

    Start Marketing Date : 2017-05-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Rivaroxaban

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Rivaroxaban

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21580

    Submission : 2008-07-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2021-090 - Rev 00

    Issue Date : 2023-02-22

    Type : Chemical

    Substance Number : 2932

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12527-0580

    Start Marketing Date : 2014-05-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Bayer Korea Ltd.

    Registration Date : 2008-06-27

    Registration Number : Su2420-3-ND

    Manufacturer Name : [Other than undifferentiated process (manufacturing of Rivaroxaban)] Bayer AG@[Undifferentiated manufacturing plant ①] Bayer AG@[Undifferentiated manufacturing plant ②] Bayer HealthCare Manufacturing Srl

    Manufacturer Address : [Other than micronization process (manufacturing of rivaroxaban)] Werksteil Elberfeld Friedrich-Ebert-Straße 217-333 42117 Wuppertal Germany@[Micronization factory ①] 51368 leverkusen@[Micronization factory ②] Via delle Groane 126 20024 Garbagnate Milanese, Italy

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Acarbose

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    02

    Acemetacin, Unmilled, milled

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    03

    Acetylsalicylic acid

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    04

    Aprotinin concentrated solution

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    05

    Blood Agar Base

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    06

    Ciprofloxacin

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    07

    Ciprofloxacin Hydrochloride

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    08

    Clotrimazole

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    09

    Cyproterone acetate

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow

    10

    Cyproterone acetate, Variant 1

    CEP/COS

    2024 ACI Convention
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    ASPIRIN; CAFFEINE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ASPIRIN; CAFFEINE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 0280-0103

    Start Marketing Date : 2023-01-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (650mg/1 65mg/1)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    CIPROFLOXACIN HYDROCHLORIDE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    CIPROFLOXACIN HYDROCHLORIDE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12527-0537

    Start Marketing Date : 2016-05-13

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    CIPROFLOXACIN HYDROCHLORIDE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    CIPROFLOXACIN HYDROCHLORIDE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12527-0540

    Start Marketing Date : 2016-09-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    ENROFLOXACIN

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ENROFLOXACIN

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12527-0801

    Start Marketing Date : 2021-08-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    ESTRADIOL BENZOATE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ESTRADIOL BENZOATE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12866-1019

    Start Marketing Date : 2017-05-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    ESTRADIOL HEMIHYDRATE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ESTRADIOL HEMIHYDRATE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12866-1018

    Start Marketing Date : 2017-05-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    ESTRADIOL HEMIHYDRATE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ESTRADIOL HEMIHYDRATE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12866-1169

    Start Marketing Date : 2017-05-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    ESTRADIOL VALERATE

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ESTRADIOL VALERATE

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12866-1008

    Start Marketing Date : 2017-05-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    ETHINYL ESTRADIOL

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ETHINYL ESTRADIOL

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12866-1168

    Start Marketing Date : 2017-05-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    ETHINYL ESTRADIOL

    Germany
    Saudi International Expo
    Not Confirmed
    arrow

    ETHINYL ESTRADIOL

    Germany
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Bayer AG

    NDC Package Code : 12866-1016

    Start Marketing Date : 2017-05-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Bayer Pharma AG and get a quotation

    Bayer Pharma AG is a supplier offers 150 products (APIs, Excipients or Intermediates).

    Find a price of Ethinyl Estradiol bulk with DMF, CEP, JDMF offered by Bayer Pharma AG

    Find a price of Iopromide bulk with DMF, CEP, JDMF offered by Bayer Pharma AG

    Find a price of Levonorgestrel bulk with DMF, CEP, JDMF offered by Bayer Pharma AG

    Find a price of Norethisterone bulk with CEP, JDMF offered by Bayer Pharma AG

    Find a price of Acarbose bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of CAS 50-28-2 bulk with DMF, JDMF offered by Bayer Pharma AG

    Find a price of Ciprofloxacin bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Ciprofloxacin Hydrochloride bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Clotrimazole bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Drospirenone bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Estradiol bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Gadobutrol bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Medroxyprogesterone Acetate bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Mesalazine bulk with JDMF offered by Bayer Pharma AG

    Find a price of Norethisterone bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Norethisterone Acetate bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Rivaroxaban bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Testosterone bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Testosterone Enanthate bulk with DMF, CEP offered by Bayer Pharma AG

    Find a price of Aspirin bulk with CEP offered by Bayer Pharma AG

    Find a price of Cyproterone Acetate bulk with CEP offered by Bayer Pharma AG

    Find a price of Diflucortolone Valerate bulk with JDMF offered by Bayer Pharma AG

    Find a price of Estriol bulk with CEP offered by Bayer Pharma AG

    Find a price of Etofenamate bulk with CEP offered by Bayer Pharma AG

    Find a price of Gestodene bulk with CEP offered by Bayer Pharma AG

    Find a price of Hydrocortisone bulk with CEP offered by Bayer Pharma AG

    Find a price of Nifedipine bulk with CEP offered by Bayer Pharma AG

    Find a price of Testosterone bulk with CEP offered by Bayer Pharma AG

    Find a price of Acemetacin bulk offered by Bayer Pharma AG

    Find a price of Alpha-Cyclodextrin bulk with DMF offered by Bayer Pharma AG

    Find a price of Aprotinin bulk offered by Bayer Pharma AG

    Find a price of Azelaic Acid bulk with DMF offered by Bayer Pharma AG

    Find a price of CAS 50-28-2 bulk with DMF offered by Bayer Pharma AG

    Find a price of Ciprofloxacin bulk with DMF offered by Bayer Pharma AG

    Find a price of Dienogest bulk with DMF offered by Bayer Pharma AG

    Find a price of Estradiol Valerate bulk with CEP offered by Bayer Pharma AG

    Find a price of Gadolinium Ethoxybenzyl Dtpa bulk with DMF offered by Bayer Pharma AG

    Find a price of Iloprost bulk with DMF offered by Bayer Pharma AG

    Find a price of Iopromide bulk with CEP offered by Bayer Pharma AG

    Find a price of Levonorgestrel bulk with DMF offered by Bayer Pharma AG

    Find a price of Molidustat bulk with DMF offered by Bayer Pharma AG

    Find a price of Moxifloxacin Hydrochloride bulk with CEP offered by Bayer Pharma AG

    Find a price of Nisoldipine bulk with DMF offered by Bayer Pharma AG

    Find a price of Norethisterone bulk with CEP offered by Bayer Pharma AG

    Find a price of Rivaroxaban bulk with DMF offered by Bayer Pharma AG

    Find a price of Testosterone Undecanoate bulk with DMF offered by Bayer Pharma AG

    Find a price of 5-Hydroxy Tryptophan bulk offered by Bayer Pharma AG

    Find a price of Agar bulk offered by Bayer Pharma AG

    Find a price of Alclometasone Dipropionate bulk offered by Bayer Pharma AG

    Find a price of Allopregnanolone bulk offered by Bayer Pharma AG

    Find a price of Amidotrizoic Acid bulk offered by Bayer Pharma AG

    Find a price of Ampicillin bulk offered by Bayer Pharma AG

    Find a price of Ampicillin Sodium bulk offered by Bayer Pharma AG

    Find a price of Ampicillin Trihydrate bulk offered by Bayer Pharma AG

    Find a price of Asoprisnil bulk offered by Bayer Pharma AG

    Find a price of Aspirin bulk offered by Bayer Pharma AG

    Find a price of Atamestane bulk offered by Bayer Pharma AG

    Find a price of Bay Y3118 bulk offered by Bayer Pharma AG

    Find a price of Beta-Cyclodextrin API bulk offered by Bayer Pharma AG

    Find a price of Betamethasone bulk offered by Bayer Pharma AG

    Find a price of Betamethasone Valerate bulk offered by Bayer Pharma AG

    Find a price of Bifonazole bulk offered by Bayer Pharma AG

    Find a price of Boldenone Undecylenate bulk offered by Bayer Pharma AG

    Find a price of CAS 53-16-7 bulk offered by Bayer Pharma AG

    Find a price of Ciprofloxacin bulk offered by Bayer Pharma AG

    Find a price of Clocortolone Acetate bulk offered by Bayer Pharma AG

    Find a price of Cyproterone Acetate bulk offered by Bayer Pharma AG

    Find a price of Danazol bulk offered by Bayer Pharma AG

    Find a price of Deflazacort bulk offered by Bayer Pharma AG

    Find a price of Entinostat bulk offered by Bayer Pharma AG

    Find a price of Estradiol Enanthate bulk offered by Bayer Pharma AG

    Find a price of Ethinamate bulk offered by Bayer Pharma AG

    Find a price of Fludarabine Phosphate bulk offered by Bayer Pharma AG

    Find a price of Fluocortin Butyl Ester bulk offered by Bayer Pharma AG

    Find a price of Gentamicin Sulfate bulk offered by Bayer Pharma AG

    Find a price of Hyaluronic Acid bulk offered by Bayer Pharma AG

    Find a price of Hydrocortisone Acetate bulk offered by Bayer Pharma AG

    Find a price of Hydrocortisone Sodium Succinate bulk offered by Bayer Pharma AG

    Find a price of Hydroxyprogesterone Caproate bulk offered by Bayer Pharma AG

    Find a price of Iloprost bulk offered by Bayer Pharma AG

    Find a price of Iotrolan bulk offered by Bayer Pharma AG

    Find a price of Ipodate bulk offered by Bayer Pharma AG

    Find a price of Isoniazid bulk offered by Bayer Pharma AG

    Find a price of Levonorgestrel bulk offered by Bayer Pharma AG

    Find a price of Lisuride bulk offered by Bayer Pharma AG

    Find a price of Lisuride Maleate bulk offered by Bayer Pharma AG

    Find a price of Lormetazepam bulk offered by Bayer Pharma AG

    Find a price of Megestrol Acetate bulk offered by Bayer Pharma AG

    Find a price of Meglumine bulk offered by Bayer Pharma AG

    Find a price of Mesterolone bulk offered by Bayer Pharma AG

    Find a price of Mestranol bulk offered by Bayer Pharma AG

    Find a price of Methyl Testosterone bulk offered by Bayer Pharma AG

    Find a price of Methylprednisolone bulk offered by Bayer Pharma AG

    Find a price of Methylprednisolone Acetate bulk offered by Bayer Pharma AG

    Find a price of Methylprednisolone Hemisuccinate bulk offered by Bayer Pharma AG

    Find a price of Muzolimine bulk offered by Bayer Pharma AG

    Find a price of Nandrolone Decanoate bulk offered by Bayer Pharma AG

    Find a price of Nandrolone Phenpropionate bulk offered by Bayer Pharma AG

    Find a price of Niclosamide bulk offered by Bayer Pharma AG

    Find a price of Nifedipine bulk offered by Bayer Pharma AG

    Find a price of Nimodipine bulk offered by Bayer Pharma AG

    Find a price of Nitrendipine bulk offered by Bayer Pharma AG

    Find a price of Norethisterone Enanthate bulk offered by Bayer Pharma AG

    Find a price of Onapristone bulk offered by Bayer Pharma AG

    Find a price of Pancuronium Bromide bulk offered by Bayer Pharma AG

    Find a price of Paracetamol bulk offered by Bayer Pharma AG

    Find a price of Pentetic Acid bulk offered by Bayer Pharma AG

    Find a price of Pirazolac bulk offered by Bayer Pharma AG

    Find a price of Prednisolone bulk offered by Bayer Pharma AG

    Find a price of Prednisolone Acetate bulk offered by Bayer Pharma AG

    Find a price of Prednisolone Sodium Phosphate bulk offered by Bayer Pharma AG

    Find a price of Prednisone bulk offered by Bayer Pharma AG

    Find a price of Quinestrol bulk offered by Bayer Pharma AG

    Find a price of Quinidine Gluconate bulk offered by Bayer Pharma AG

    Find a price of Radium-224 bulk offered by Bayer Pharma AG

    Find a price of Rolipram bulk offered by Bayer Pharma AG

    Find a price of Spironolactone bulk offered by Bayer Pharma AG

    Find a price of Sulfasalazine bulk offered by Bayer Pharma AG

    Find a price of Sulfathiazole Sodium bulk offered by Bayer Pharma AG

    Find a price of Testosterone Propionate bulk offered by Bayer Pharma AG

    Find a price of Trichlorfon bulk offered by Bayer Pharma AG

    Find a price of Water bulk offered by Bayer Pharma AG

    Find a price of FACIL, PERSONNEL & GEN OPERATING PROCEDS FOR MANATI, PR PLANT bulk offered by Bayer Pharma AG

    Find a price of GENERAL OPERATING PROCEDURE bulk offered by Bayer Pharma AG

    Find a price of FACILITY AND OPERATING PROCEDURES IN DORMAGEN, WEST GERMANY bulk offered by Bayer Pharma AG

    Find a price of ZK807834 bulk offered by Bayer Pharma AG

    Find a price of ULTRALANUM CREAM PLAIN bulk offered by Bayer Pharma AG

    Find a price of EOB-DTPA bulk offered by Bayer Pharma AG

    Find a price of FACILITIES AND PERSONNEL IN LEVERKUSEN, GERMANY bulk offered by Bayer Pharma AG

    Find a price of DROXONE bulk offered by Bayer Pharma AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN POINTE CLAIRE, QUEBEC. bulk offered by Bayer Pharma AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Bayer Pharma AG

    Find a price of GENERAL OPERATING PROCEDURES bulk offered by Bayer Pharma AG

    Find a price of HYDROXY ACID bulk offered by Bayer Pharma AG

    Find a price of ZK 112 119(6-BOCIP) bulk offered by Bayer Pharma AG

    Find a price of GENERAL OPERATING PROCEDURES FOR BULK PRODUCTS bulk offered by Bayer Pharma AG

    Find a price of BOVINE THROMBIN bulk offered by Bayer Pharma AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND PROCEDURES IN WEIMAR, GERMANY bulk offered by Bayer Pharma AG

    Find a price of 17 ALPHA-ETHINYL-19-NOR-TESTOSTERONE bulk offered by Bayer Pharma AG

    Find a price of FACILITIES FOR THE MFG OF LIQUID & SOFT GELATIN CAPSULE PRODUCTS bulk offered by Bayer Pharma AG

    Find a price of THE COMPLETE BUTYL PRODUCT LINE bulk offered by Bayer Pharma AG

    Find a price of GEN. OPERATING PROCEDS FOR BULK PRODUCTS-SCHERING AG BERGKAMEN PLANT bulk offered by Bayer Pharma AG

    Find a price of FACILITY IN DARDILLY, FRANCE bulk offered by Bayer Pharma AG

    Find a price of MFG. AND CONTROL OF CLINICAL SUPPLIES IN BERLIN, W. GERMANY bulk offered by Bayer Pharma AG

    Find a price of PYNASUNATE bulk offered by Bayer Pharma AG

    Find a price of FACILITIES AND PERSONNEL AT WUPPERTAL, WEST GERMANY bulk offered by Bayer Pharma AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GARBAGNATE MILANESE ITALY. bulk offered by Bayer Pharma AG

    Find a price of 17A-ETHINYL-19-NOR-TESTOSTERONE ACETATE bulk offered by Bayer Pharma AG

    Find a price of Fluocortolone Caproate bulk offered by Bayer Pharma AG

    Find a price of Fluocortolone Pivalate bulk offered by Bayer Pharma AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search